GNPX
Income statement / Annual
Last year (2024), Genprex, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Genprex, Inc.'s net income was -$21.39 B.
See Genprex, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$15.00 K
|
$23.83 M
|
$22.53 K
|
$22.78 K
|
$13.07 K
|
$5.89 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$15.00 K
|
-$23.83 M
|
-$22.53 K
|
-$22.78 K
|
-$13.07 K
|
-$5.89 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.54 M
|
$17.62 M
|
$11.51 M
|
$8.61 M
|
$7.30 M
|
$1.97 M
|
$971.43 K
|
$289.93 K
|
$354.88 K
|
$201.96 K
|
| General & Administrative Expenses |
$10.63 B
|
$13.44 M
|
$12.30 M
|
$10.97 M
|
$10.64 M
|
$8.70 M
|
$11.39 M
|
$3.02 M
|
$3.78 M
|
$865.70 K
|
| Selling & Marketing Expenses |
-$10.62 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.63 M
|
$13.44 M
|
$12.30 M
|
$10.97 M
|
$10.64 M
|
$8.70 M
|
$11.39 M
|
$3.02 M
|
$3.78 M
|
$865.70 K
|
| Other Expenses |
$0.00
|
$0.00
|
$25.58 K
|
$22.53 K
|
$22.78 K
|
$13.07 K
|
$5.89 K
|
$3.24 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$21.17 M
|
$31.06 M
|
$23.83 M
|
$19.60 M
|
$17.96 M
|
$10.68 M
|
$12.36 M
|
$3.31 M
|
$4.13 M
|
$1.07 M
|
| Cost And Expenses |
-$21.17 M
|
$31.08 M
|
$23.83 M
|
$19.60 M
|
$17.96 M
|
$10.68 M
|
$12.36 M
|
$3.31 M
|
$4.13 M
|
$1.07 M
|
| Interest Income |
$63.57 K
|
$215.11 K
|
$90.10 K
|
$5.13 K
|
$18.81 K
|
$27.91 K
|
$29.18 K
|
$80.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$37.98 K
|
$1.89 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$15.00 K
|
$25.58 K
|
$22.53 K
|
$22.78 K
|
$13.07 K
|
$5.89 K
|
$3.24 K
|
$862.00
|
$2.06 K
|
| EBITDA |
-$21.10 M |
-$31.06 M |
-$23.81 M |
-$20.65 M |
-$17.94 M |
-$10.64 M |
-$12.33 M |
-$3.31 M |
-$4.13 M |
-$1.07 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$215.11 K
|
$90.10 K
|
$5.13 K
|
$18.81 K
|
$27.90 K
|
-$8.80 K
|
-$1.81 K
|
$0.00
|
$0.00
|
| Income Before Tax |
-$21.39 B
|
-$30.86 M
|
-$23.74 M
|
-$19.60 M
|
-$17.94 M
|
-$10.65 M
|
-$12.37 M
|
-$3.31 M
|
-$4.13 M
|
-$1.07 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$5.72 M
|
-$5.13 K
|
-$18.81 K
|
-$130.89 K
|
$29.18 K
|
$80.00
|
$0.00
|
$0.00
|
| Net Income |
-$21.39 B
|
-$30.86 M
|
-$29.46 M
|
-$19.59 M
|
-$17.92 M
|
-$10.65 M
|
-$12.37 M
|
-$3.31 M
|
-$4.13 M
|
-$1.07 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-5339.07 |
-22.58 |
-24.59 |
-16.64 |
-20.18 |
-26.64 |
-35.97 |
-11.55 |
-15.3 |
-23.25 |
| EPS Diluted |
-5339.07 |
-22.56 |
-24.58 |
-16.64 |
-20.18 |
-26.59 |
-35.94 |
-11.53 |
-15.26 |
-22.93 |
| Weighted Average Shares Out |
$4.01 M
|
$1.37 M
|
$1.20 M
|
$1.18 M
|
$888.00 K
|
$400.00 K
|
$344.00 K
|
$287.00 K
|
$270.00 K
|
$46.00 K
|
| Weighted Average Shares Out Diluted |
$4.01 M
|
$1.37 M
|
$1.20 M
|
$1.18 M
|
$888.07 K
|
$400.68 K
|
$344.28 K
|
$287.50 K
|
$270.87 K
|
$46.66 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
